Literature DB >> 26735858

Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac.

Amir H Afrogheh1, Frederick A Jakobiec, Rebecca Hammon, Hans E Grossniklaus, James Rocco, Neal I Lindeman, Peter M Sadow, William C Faquin.   

Abstract

High-risk human papilloma virus (HR-HPV) is a well-established causative agent of oropharyngeal squamous cell carcinoma (SCC). In addition, HR-HPV has occasionally been reported to be present in dysplastic and malignant lesions of the conjunctiva and lacrimal sac, although its overall incidence and etiological role in periocular SCC are controversial. Sequential surgical samples of 52 combined cases of invasive SCC (I-SCC) and SCC in situ (SCCIS) from 2 periocular sites (conjunctiva and lacrimal sac) diagnosed over a 14-year period (2000 to 2014) were selected for evaluation, and relevant patient characteristics were documented. p16 immunohistochemistry was performed as a screening test. All p16-positive cases were further evaluated for HR-HPV using DNA in situ hybridization (DNA ISH), and a subset was also analyzed by polymerase chain reaction (PCR). Of 43 ocular surface squamous neoplasias (OSSNs), 30% (n=13; 8 SCCIS and 5 I-SCC cases) were positive for HR-HPV. HPV-positive OSSNs occurred in 8 men and 5 women with a mean age of 60 years (range, 39 to 94 y). HPV type-16 was detected in all conjunctival cases evaluated by PCR. All 5 conjunctival I-SCCs were nonkeratinizing (n=4) or partially keratinizing (n=1) and managed by simple excision. In contrast, HPV-negative conjunctival I-SCCs were predominantly keratinizing (11 keratinizing and 2 nonkeratinizing). Of 9 lacrimal sac I-SCCs (LSSCCs), 66.7% (n=6) were positive for HR-HPV by p16 and DNA ISH; HPV subtypes were HPV-16 (n=5) and HPV-58 (n=1). In addition, 2 p16-positive cases with negative DNA ISH results were HR-HPV positive (HPV-16 and HPV-33) when evaluated by PCR, suggesting that the rate of HR-HPV positivity among the LSSCCs may be as high as 89% (n=8). The combined group of HR-HPV-positive LSSCCs was seen in 4 men and 4 women with a mean age of 60 years (range, 34 to 71 y). Seven of the 8 HPV-positive LSSCCs (87.5%) had a nonkeratinizing or partially keratinizing histomorphology, whereas 1 case (12.5%) was predominantly keratinizing. The presence of HR-HPV in 30% of OSSNs and at least 66.7% of LSSCCs suggests the possibility of an etiologic role for HR-HPV at these sites.

Entities:  

Mesh:

Year:  2016        PMID: 26735858     DOI: 10.1097/PAS.0000000000000581

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

1.  Conjunctival Squamous Cell Neoplasia Associated With Ocular Cicatricial Pemphigoid.

Authors:  Catherine J Choi; Frederick A Jakobiec; Fouad R Zakka; C Stephen Foster; James Chodosh; Suzanne K Freitag
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 Nov/Dec       Impact factor: 1.746

2.  Villous Sebaceous Adenoma Arising from the Caruncular Surface Squamous Epithelium.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-03-10

3.  Human papillomavirus (HPV)-associated trilateral squamous neoplasia in immunocompetent individual.

Authors:  Alfonso Iovieno; Simonetta Piana; Laura Chiesi; Cristina Fodero; Luigi Fontana
Journal:  Int Ophthalmol       Date:  2017-06-06       Impact factor: 2.031

4.  [Treatment-refractory epiphora after dacryocystorhinostomy-role of imaging and histopathology].

Authors:  Anne-Cécile Vandebroek; Annekatrin Rickmann; Karl Boden; Gesine Szurman; Victoria Bozzato; Berthold Seitz; Fabian N Fries
Journal:  Ophthalmologie       Date:  2022-06-15

5.  Detection of Human Papillomavirus in Squamous Lesions of the Conjunctiva Using RNA and DNA In-Situ Hybridization.

Authors:  Cornelia Peterson; Rupin N Parikh; Meleha T Ahmad; Ashley A Campbell; Yassine Daoud; Nicholas Mahoney; Sepideh Siadati; Charles G Eberhart
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

6.  Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil.

Authors:  Wen Geng; Jia-Song Wang; Bing-Jie Shi; Hua-Tao Xie; Ming-Chang Zhang
Journal:  Ophthalmol Ther       Date:  2022-06-15

7.  A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.

Authors:  Christine A Kiire; Rosalind M K Stewart; Sathish Srinivasan; Heinrich Heimann; Stephen B Kaye; Baljean Dhillon
Journal:  Eye (Lond)       Date:  2018-12-28       Impact factor: 3.775

8.  Assessment of p16 expression and HPV infection in adenoid cystic carcinoma of the lacrimal gland.

Authors:  Yuchuan Wang; Yuan Tian; Jinyong Lin; Luxia Chen; Liming Wang; Peng Hao; Ruifang Han; Ming Ying; Xuan Li; Xin Tang
Journal:  Mol Vis       Date:  2018-02-06       Impact factor: 2.367

9.  Treatment and Pathology of an Unusual Large Carcinoma of the Conjunctiva.

Authors:  Thomas Stahnke; Ngoy Kilangalanga; Steffi Knappe; Rudolf F Guthoff; Andreas Erbersdobler
Journal:  Case Rep Ophthalmol Med       Date:  2018-04-01

10.  Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana.

Authors:  Lauren E Merz; Osei Afriyie; Evelyn Jiagge; Ernest Adjei; Susan K Foltin; Megan L Ludwig; Jonathan B McHugh; J Chad Brenner; Sofia D Merajver
Journal:  Health Sci Rep       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.